Ed Wraith

1.9k total citations
24 papers, 910 citations indexed

About

Ed Wraith is a scholar working on Physiology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Ed Wraith has authored 24 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Physiology, 6 papers in Organic Chemistry and 5 papers in Epidemiology. Recurrent topics in Ed Wraith's work include Lysosomal Storage Disorders Research (20 papers), Trypanosoma species research and implications (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Ed Wraith is often cited by papers focused on Lysosomal Storage Disorders Research (20 papers), Trypanosoma species research and implications (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Ed Wraith collaborates with scholars based in United Kingdom, United States and France. Ed Wraith's co-authors include Susmito Biswas, Jane Ashworth, Iva Lloyd, Martin Connock, Christine Lavery, David Moore, I. Christopher Lloyd, John Thorne, David G. Hughes and R. A. Cowie and has published in prestigious journals such as Blood, Hepatology and The Journal of Pediatrics.

In The Last Decade

Ed Wraith

23 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ed Wraith United Kingdom 11 718 242 203 149 135 24 910
J E Wraith United Kingdom 11 571 0.8× 233 1.0× 192 0.9× 92 0.6× 79 0.6× 12 740
Elke Miebach Germany 13 989 1.4× 521 2.2× 291 1.4× 133 0.9× 121 0.9× 15 1.1k
Laila Arash Germany 7 565 0.8× 284 1.2× 174 0.9× 64 0.4× 81 0.6× 8 629
Dawn A. Laney United States 13 871 1.2× 374 1.5× 316 1.6× 162 1.1× 89 0.7× 43 1.0k
A Mehta United Kingdom 11 587 0.8× 248 1.0× 173 0.9× 99 0.7× 74 0.5× 36 688
Karen Tylee United Kingdom 16 580 0.8× 259 1.1× 158 0.8× 104 0.7× 80 0.6× 45 704
R J Desnick United States 12 778 1.1× 309 1.3× 212 1.0× 245 1.6× 95 0.7× 20 941
F. Dehout Belgium 7 926 1.3× 449 1.9× 346 1.7× 104 0.7× 113 0.8× 13 1.0k
S. Wendt Germany 4 526 0.7× 281 1.2× 178 0.9× 65 0.4× 47 0.3× 8 588
Norberto Guelbert Argentina 16 514 0.7× 216 0.9× 232 1.1× 148 1.0× 27 0.2× 39 651

Countries citing papers authored by Ed Wraith

Since Specialization
Citations

This map shows the geographic impact of Ed Wraith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed Wraith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed Wraith more than expected).

Fields of papers citing papers by Ed Wraith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ed Wraith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed Wraith. The network helps show where Ed Wraith may publish in the future.

Co-authorship network of co-authors of Ed Wraith

This figure shows the co-authorship network connecting the top 25 collaborators of Ed Wraith. A scholar is included among the top collaborators of Ed Wraith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ed Wraith. Ed Wraith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Balwani, Manisha, Catherine Breen, Gregory M. Enns, et al.. (2013). Clinical Effect And Safety Profile of Recombinant Human Lysosomal Acid Lipase in Patients With Cholesteryl Ester Storage Disease. Hepatology. 58(3). 950–957. 77 indexed citations
2.
Searle, Claire, et al.. (2013). A Large Intragenic Deletion in the ACADM Gene Can Cause MCAD Deficiency but is not Detected on Routine Sequencing. JIMD Reports. 11. 13–16. 2 indexed citations
3.
Enns, Gregory M., Manisha Balwani, Patrick Deegan, et al.. (2012). Initial Human Experience with SBC-102, a Recombinant Enzyme Replacement Therapy in Adults with Lysosomal Acid Lipase Deficiency. Molecular Genetics and Metabolism. 105(2). S29–S29. 5 indexed citations
4.
Bigger, Brian, Kia Langford‐Smith, Jean Mercer, et al.. (2011). Serum HCII-T and urinary DS:CS ratio are both predictive biomarkers of treatment outcome in patients with MPS I, II and VI. Molecular Genetics and Metabolism. 102(2). S8–S9. 1 indexed citations
5.
Héron, Bénédicte, Yann Mikaeloff, Roseline Froissart, et al.. (2010). Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. American Journal of Medical Genetics Part A. 155(1). 58–68. 128 indexed citations
6.
Jacklin, Elizabeth, Jackie Imrie, Simon Jones, & Ed Wraith. (2010). 70. Review of 11 patients with NPC1 treated with miglustat. Molecular Genetics and Metabolism. 99(2). S22–S22. 3 indexed citations
7.
Wraith, Ed, et al.. (2009). 154. Disease stability in patients with Niemann–Pick disease type C treated with miglustat. Molecular Genetics and Metabolism. 96(2). S46–S46. 3 indexed citations
8.
Patterson, Marc C., Eugen Mengel, Wuh‐Liang Hwu, et al.. (2009). 100. A multicentre retrospective survey of miglustat in patients with Niemann-Pick type C disease. Molecular Genetics and Metabolism. 96(2). S34–S34.
9.
Wraith, Ed. (2009). New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat. Therapeutics and Clinical Risk Management. 5. 877–877. 55 indexed citations
10.
Moore, David, Martin Connock, Ed Wraith, & Christine Lavery. (2008). The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK. Orphanet Journal of Rare Diseases. 3(1). 24–24. 107 indexed citations
11.
Wraith, Ed, Michael Beck, Jackie Imrie, et al.. (2008). 112. Safety monitoring of miglustat in patients with Niemann-Pick disease type C. Molecular Genetics and Metabolism. 93(2). 43–43. 1 indexed citations
12.
Eng, Christine M., Joseph Muenzer, Ed Wraith, et al.. (2007). 39 Formation of a Lysosomal Disease Testing Network to enhance the delivery of diagnostic services to patients with lysosomal storage disorders. Molecular Genetics and Metabolism. 92(4). 20–20. 1 indexed citations
13.
Tylee, Karen, Alan Cooper, Margaret J. Thornley, et al.. (2007). Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease. Bone Marrow Transplantation. 39(4). 207–210. 46 indexed citations
14.
Eng, Christine M., Joseph Muenzer, Ed Wraith, et al.. (2007). 29 Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome). Molecular Genetics and Metabolism. 92(4). 18–18. 2 indexed citations
15.
Ashworth, Jane, Susmito Biswas, Ed Wraith, & Iva Lloyd. (2006). Mucopolysaccharidoses and the Eye. Survey of Ophthalmology. 51(1). 1–17. 192 indexed citations
16.
Cimaz, Rolando, Claudia M. Haase, Giovanni V. Coppa, et al.. (2006). Attenuated type I mucopolysaccharidosis in the differential diagnosis of juvenile idiopathic arthritis: a series of 13 patients with Scheie syndrome.. PubMed. 24(2). 196–202. 34 indexed citations
17.
Wraith, Ed, John J. Hopwood, Maria Fuller, Peter J. Meikle, & Doug A. Brooks. (2005). Laronidase Treatment of Mucopolysaccharidosis I. BioDrugs. 19(1). 1–7. 34 indexed citations
18.
Ashworth, Jane, Susmito Biswas, Ed Wraith, & I. Christopher Lloyd. (2005). The ocular features of the mucopolysaccharidoses. Eye. 20(5). 553–563. 97 indexed citations
19.
20.
Robinson, Mark, F. White, Maureen Cleary, et al.. (2000). Increased risk of vitamin B12 deficiency in patients with phenylketonuria on an unrestricted or relaxed diet. The Journal of Pediatrics. 136(4). 545–547. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J E Wraith Breakdown of academic impact, for papers by Elke Miebach Breakdown of academic impact, for papers by Laila Arash Breakdown of academic impact, for papers by Dawn A. Laney Breakdown of academic impact, for papers by A Mehta Breakdown of academic impact, for papers by Karen Tylee Breakdown of academic impact, for papers by R J Desnick Breakdown of academic impact, for papers by F. Dehout Breakdown of academic impact, for papers by S. Wendt Breakdown of academic impact, for papers by Norberto Guelbert
Rankless by CCL
2026